NOVO-NORDISK A S

About

Novo Nordisk A/S is a global healthcare company specializing in the research, development, and manufacturing of pharmaceutical products, with a primary focus on diabetes care and obesity treatment. The company holds a leading market position in these areas, driven by its portfolio of insulin analogs and GLP-1-based therapies. Additionally, Novo Nordisk operates within hemophilia care and growth hormone disorders, maintaining a significant presence in the biopharmaceutical industry.